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Given the discovery of the amyloid nature of the RIPK1;RIPK3 necrosome 29 , we initially sought to 1 1 0 determine whether the RHIM in M45 is amyloidogenic. A peptide of 19 residues, corresponding to 1 1 1 the M45 RHIM sequence, readily assembled into long fibrils with amyloid morphology (Fig. 1a, b) .
In order to investigate the nature of the interactions between M45 and host proteins, we prepared RHIM-containing regions shown to support interactions between these two proteins, i.e. RIPK1-(497-583) and 29 . Two RHIM-encompassing fragments of M45 were N-terminal residues of M45 have previously been shown to provide protection against some forms 1 2 3 of cell death 23 and to inhibit ZBP-1 signalling 7 . We compared the ability of the 1-90 and 1-277 regions of M45 to protect against TNFR-induced A1 can induce dimerization of the gyrase subunit, to substitute for the potential dimerisation of the with RNR large and small subunits in the intact viral protein. Fig. 1c shows that the 90-residue and 1 3 2 277-residue portions of M45 protect human cells from TNFR-induced necroptosis through the 1 3 3 RIPK1:RIPK3 pathway to a similar extent, in the range 70-90%. This is independent of the addition 1 3 4 of coumermycin A1, indicating that dimerisation of M45 is not necessary for its role in inhibition of 1 3 5 host cell death. For the majority of biophysical experiments we have therefore probed RHIM-driven 1 3 6
interactions using the minimum necrosome-forming regions of RIPK1 and RIPK3 29 and the 90- residue N-terminal portion of M45, which displays the ability to inhibit TNFR-induced necroptosis. The wild type core tetrad is critical for amyloid formation by M45 and RIPK1 but not RIPK3
The RHIM-containing regions were expressed as fusion proteins with His-Ub or His-FP to provide 1 4 1 a means to study the kinetics of hetero-amyloid assembly. These fusion proteins were purified and responses if caspase-8 is inhibited by viral or chemical inhibitors 3 . We propose that the presence of by intermolecular interactions between the prion-like domains, however the in vivo significance of 3 5 0 heteromeric fibril assembly by these proteins is currently less clear than is the case for RHIM-based assembly. Further mutagenesis studies could identify the M45-derived interactions responsible. The interactions would explain the branching and network morphology we observe in our heteromeric 3 8 2 assemblies ( Fig. 5a ,f; Supplementary Fig. 2 ). The concentration of viral protein in the cell may also It is noteworthy that in our experiments the AAAA mutation of the core tetrad in RIPK3 387-518 does 3 9 0 not abolish self-assembly into an amyloid structure while this mutation in RIPK1 497-583 and M45 1-90 3 9 1 prevents self-assembly. This indicates that residues outside the tetrad of RIPK3 can support 3 9 2 oligomerisation. These remain to be identified by further mutagenesis and structural studies of the 3 9 3 entire RIPK3 RHIM. Although calculations based on the RIPK1:RIPK3 core structure suggest that 3 9 4 RIPK3:RIPK3 homo-amyloid formation is less favourable than RIPK1:RIPK3 or RIPK1:RIPK1 32 , 3 9 5 the formation of the RIPK1:RIPK3 necrosome is known to nucleate further polymerisation of 3 9 6
RIPK3 that leads to activation of RIPK3 and interaction with MLKL 40 . The results of other studies 3 9 7
show that the RHIM-based interactions of M45 with cellular partners prevent ZBP1-induced RIPK3 3 9 8 phosphorylation 7 and autophosphorylation of RIPK3 when co-expressed in 293T cells 42 . HSV-1 3 9 9
and -2 encode RHIM-containing proteins, ICP-6 and ICP10, which have been shown to protect heteromeric amyloids with viral proteins may therefore be general mechanism for modulation of interactions. Additionally, necroptosis is increasingly recognized in pathophysiological processes 4 1 9
including ischaemia-reperfusion injury, and inflammation of the skin and intestinal epithelium 13, 47 .
Any development of therapies that target the necroptosis pathway will benefit from an 4 2 1 understanding of the structural basis for viral inhibition of RHIM-based signaling. homomeric amyloids, respectively. tagged protein is coloured magenta and the signal from the YPet-tagged protein is coloured green. showing associated globular domains (e.g. kinase or RNR, coloured green) flanking either side of 5 2 7 the amyloid core formed by RHIMs (coloured grey). RodA in urea-containing buffer and allowed to assemble upon removal of urea by dialysis. were used to detect Thioflavin T fluorescence, YPet and mCHERRY respectively. resuspended in 20 mM NaH 2 PO 4 , 150 mM NaCl, 0.5 mM DTT, pH 7.4 (insoluble), pellet from 5 5 8 centrifugation treated with 2% SDS for 10 min at 37 °C and then separated again into supernatant 5 5 9
(SDS-soluble) and pellet (SDS-insoluble). SDS-insoluble material was incubated in 8 M urea to 5 6 0 solubilise material for detection by PAGE. This SDS analysis was performed once. Samples were removed and prepared with 4% glycerol and 0.0008% bromophenol blue and 0 or 2% 7 0 1 SDS, incubated at room temperature for 10 min and then analysed by electrophoresis using a 1% 7 0 2 agarose gel running in TAE buffer containing 0.1% SDS. Gels were imaged on a Bio-Rad Chemi-7 0 3
Doc imaging system with 605/50nm and 695/55nm emission filters. In order to study the stability of Scientific) and then analysed by SDS PAGE. with the lentivirus particles in the presence of polybrene (Santa Cruz), and after 3 days G418 7 4 5 (Roche) was added for the subsequent 10 days to select for successfully transduced cells. M45 1-90 -7 4 6 gyrase, M45 1-277 -gyrase or empty-vector-control transduced HT-29s were seeded in 96 well plates 7 4 7 (10 4 cells/well) and allowed to adhere for 6 h before treating with 900 nM coumermycin A1 (Enzo) 
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